IQVIA HOLDINGS INC (IQV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:IQV - US46266C1053 - Common Stock
224.9 USD
+7.79 (+3.59%)
224.9 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to IQV. IQV was compared to 58 industry peers in the Life Sciences Tools & Services industry. IQV scores excellent on profitability, but there are concerns on its financial health. IQV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year IQV was profitable.
In the past year IQV had a positive cash flow from operations.
IQV had positive earnings in each of the past 5 years.
IQV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.47%, IQV is doing good in the industry, outperforming 79.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of 20.83%, IQV belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
IQV has a better Return On Invested Capital (9.77%) than 86.21% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IQV is below the industry average of 13.56%.
The last Return On Invested Capital (9.77%) for IQV is above the 3 year average (8.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 20.83% | ||
| ROIC | 9.77% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
1.3 Margins
The Profit Margin of IQV (8.07%) is better than 77.59% of its industry peers.
IQV's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 14.20%, IQV is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
In the last couple of years the Operating Margin of IQV has grown nicely.
The Gross Margin of IQV (33.78%) is worse than 63.79% of its industry peers.
In the last couple of years the Gross Margin of IQV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.2% | ||
| PM (TTM) | 8.07% | ||
| GM | 33.78% |
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IQV is destroying value.
The number of shares outstanding for IQV has been reduced compared to 1 year ago.
Compared to 5 years ago, IQV has less shares outstanding
The debt/assets ratio for IQV is higher compared to a year ago.
2.2 Solvency
IQV has an Altman-Z score of 2.06. This is not the best score and indicates that IQV is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of IQV (2.06) is comparable to the rest of the industry.
The Debt to FCF ratio of IQV is 6.76, which is on the high side as it means it would take IQV, 6.76 years of fcf income to pay off all of its debts.
IQV has a better Debt to FCF ratio (6.76) than 62.07% of its industry peers.
A Debt/Equity ratio of 2.08 is on the high side and indicates that IQV has dependencies on debt financing.
The Debt to Equity ratio of IQV (2.08) is worse than 84.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.08 | ||
| Debt/FCF | 6.76 | ||
| Altman-Z | 2.06 |
ROIC/WACC0.99
WACC9.84%
2.3 Liquidity
A Current Ratio of 0.70 indicates that IQV may have some problems paying its short term obligations.
The Current ratio of IQV (0.70) is worse than 94.83% of its industry peers.
IQV has a Quick Ratio of 0.70. This is a bad value and indicates that IQV is not financially healthy enough and could expect problems in meeting its short term obligations.
IQV's Quick ratio of 0.70 is on the low side compared to the rest of the industry. IQV is outperformed by 93.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
IQV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.09%.
IQV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.72% yearly.
Looking at the last year, IQV shows a small growth in Revenue. The Revenue has grown by 3.85% in the last year.
Measured over the past years, IQV shows a small growth in Revenue. The Revenue has been growing by 6.80% on average per year.
EPS 1Y (TTM)7.09%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%5.63%
Revenue 1Y (TTM)3.85%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.24%
3.2 Future
Based on estimates for the next years, IQV will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.39% on average per year.
The Revenue is expected to grow by 5.88% on average over the next years.
EPS Next Y7.83%
EPS Next 2Y8.21%
EPS Next 3Y9.12%
EPS Next 5Y10.39%
Revenue Next Year5.27%
Revenue Next 2Y5.28%
Revenue Next 3Y5.47%
Revenue Next 5Y5.88%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.34, IQV is valued on the expensive side.
Based on the Price/Earnings ratio, IQV is valued cheaper than 89.66% of the companies in the same industry.
IQV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.45.
With a Price/Forward Earnings ratio of 17.24, IQV is valued on the expensive side.
Based on the Price/Forward Earnings ratio, IQV is valued cheaper than 91.38% of the companies in the same industry.
IQV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.34 | ||
| Fwd PE | 17.24 |
4.2 Price Multiples
IQV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IQV is cheaper than 87.93% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IQV is valued cheaper than 89.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.29 | ||
| EV/EBITDA | 15.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IQV does not grow enough to justify the current Price/Earnings ratio.
IQV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.47
PEG (5Y)1.65
EPS Next 2Y8.21%
EPS Next 3Y9.12%
5. Dividend
5.1 Amount
No dividends for IQV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
224.9
+7.79 (+3.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.98%
Inst Owner Change-2.31%
Ins Owners0.86%
Ins Owner Change-0.07%
Market Cap38.23B
Revenue(TTM)15.90B
Net Income(TTM)1.28B
Analysts83.45
Price Target252.11 (12.1%)
Short Float %2.7%
Short Ratio2.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.2%
Min EPS beat(2)-0.04%
Max EPS beat(2)0.45%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-0.62%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)0.59%
EPS beat(16)12
Avg EPS beat(16)1.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.01%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)0.07%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)6
Avg Revenue beat(16)-0.16%
PT rev (1m)14.25%
PT rev (3m)13.59%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)-0.17%
EPS NY rev (1m)0.23%
EPS NY rev (3m)0.21%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.34 | ||
| Fwd PE | 17.24 | ||
| P/S | 2.4 | ||
| P/FCF | 17.29 | ||
| P/OCF | 13.64 | ||
| P/B | 6.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.07 |
EPS(TTM)11.63
EY5.17%
EPS(NY)13.05
Fwd EY5.8%
FCF(TTM)13.01
FCFY5.78%
OCF(TTM)16.49
OCFY7.33%
SpS93.55
BVpS36.24
TBVpS-85.26
PEG (NY)2.47
PEG (5Y)1.65
Graham Number97.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.47% | ||
| ROE | 20.83% | ||
| ROCE | 11.17% | ||
| ROIC | 9.77% | ||
| ROICexc | 10.83% | ||
| ROICexgc | N/A | ||
| OM | 14.2% | ||
| PM (TTM) | 8.07% | ||
| GM | 33.78% | ||
| FCFM | 13.9% |
ROA(3y)4.83%
ROA(5y)3.91%
ROE(3y)21.26%
ROE(5y)16.88%
ROIC(3y)8.99%
ROIC(5y)7.35%
ROICexc(3y)9.76%
ROICexc(5y)7.99%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.28%
ROCE(5y)8.4%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y16.83%
ROICexc growth 5Y22.05%
OM growth 3Y13.09%
OM growth 5Y13.9%
PM growth 3Y8.58%
PM growth 5Y38.92%
GM growth 3Y1.42%
GM growth 5Y0.42%
F-Score5
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.08 | ||
| Debt/FCF | 6.76 | ||
| Debt/EBITDA | 3.78 | ||
| Cap/Depr | 52.48% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 82.76% | ||
| Profit Quality | 172.33% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 2.06 |
F-Score5
WACC9.84%
ROIC/WACC0.99
Cap/Depr(3y)57.12%
Cap/Depr(5y)53.97%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.59%
Profit Quality(3y)136.6%
Profit Quality(5y)225.89%
High Growth Momentum
Growth
EPS 1Y (TTM)7.09%
EPS 3Y7.25%
EPS 5Y11.72%
EPS Q2Q%5.63%
EPS Next Y7.83%
EPS Next 2Y8.21%
EPS Next 3Y9.12%
EPS Next 5Y10.39%
Revenue 1Y (TTM)3.85%
Revenue growth 3Y3.55%
Revenue growth 5Y6.8%
Sales Q2Q%5.24%
Revenue Next Year5.27%
Revenue Next 2Y5.28%
Revenue Next 3Y5.47%
Revenue Next 5Y5.88%
EBIT growth 1Y4.3%
EBIT growth 3Y17.1%
EBIT growth 5Y21.64%
EBIT Next Year21.15%
EBIT Next 3Y11.05%
EBIT Next 5Y9.71%
FCF growth 1Y67.37%
FCF growth 3Y-2.8%
FCF growth 5Y20.42%
OCF growth 1Y42.92%
OCF growth 3Y-2.63%
OCF growth 5Y13.9%
IQVIA HOLDINGS INC / IQV FAQ
Can you provide the ChartMill fundamental rating for IQVIA HOLDINGS INC?
ChartMill assigns a fundamental rating of 5 / 10 to IQV.
What is the valuation status for IQV stock?
ChartMill assigns a valuation rating of 6 / 10 to IQVIA HOLDINGS INC (IQV). This can be considered as Fairly Valued.
Can you provide the profitability details for IQVIA HOLDINGS INC?
IQVIA HOLDINGS INC (IQV) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for IQV stock?
The Earnings per Share (EPS) of IQVIA HOLDINGS INC (IQV) is expected to grow by 7.83% in the next year.
Can you provide the dividend sustainability for IQV stock?
The dividend rating of IQVIA HOLDINGS INC (IQV) is 0 / 10 and the dividend payout ratio is 0%.